1-3 of 3
Sridhar Chaganti
Close
Sort by
Journal Articles

Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis

Edward Poynton, Emily Chernucha, James Day, Catherine Prodger, David Hopkins, Pallav Rakesh, Tess O’Neill, Nisha Thakrar, Ayse Akarca, Esraa Jamal, Ayesha Ali, Amy A. Kirkwood, Sabine Pomplun, Teresa Marafioti, Maria Calaminici, Paul Greaves, Sridhar Chaganti, Pam McKay, Jeffery Smith, Toby A. Eyre, Nicolas Martinez-Calle, Kate Cwynarski, Christopher P. Fox, Jessica Okosun
Journal: Blood Advances
Blood Adv (2024) 8 (7): 1772–1775.
https://doi.org/10.1182/bloodadvances.2023011426
Published: 2024
Includes: Supplemental data
Journal Articles

Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma

Claire Roddie, Lorna Neill, Wendy Osborne, Sunil Iyengar, Eleni Tholouli, David Irvine, Sridhar Chaganti, Caroline Besley, Adrian Bloor, Ceri Jones, Ben Uttenthal, Rod Johnson, Robin Sanderson, Kathleen Cheok, Maria Marzolini, William Townsend, Maeve O'Reilly, Amy A. Kirkwood, Andrea Kuhnl
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2872–2883.
https://doi.org/10.1182/bloodadvances.2022009019
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1/2 study of thiotepa-based immunochemotherapy in relapsed/refractory primary CNS lymphoma: the TIER trial

Clinical Trials & Observations
Christopher P. Fox, Ayesha S. Ali, Graham McIlroy, Steffi Thust, Nicolás Martinez-Calle, Aimee E. Jackson, Louise M. Hopkins, Catherine M. Thomas, Shireen Kassam, Josh Wright, Sridhar Chaganti, Jeffery Smith, Ian Chau, Dominic Culligan, Kim M. Linton, Graham P. Collins, Andrés J. M. Ferreri, David Lewis, Andrew J. Davies, Rod Johnson, Dorothee P. Auer, Kate Cwynarski
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4073–4082.
https://doi.org/10.1182/bloodadvances.2021004779
Published: 2021
Includes: Supplemental data